Merck Immunotherapy Drug Shines In Lung Cancer Study
Research finds that more than two-thirds of lung cancer patients who received Keytruda plus chemotherapy would be alive a year later, compared with about half of people who only got chemotherapy.
Read more on NPR
April 17, 2018 at 04:43AM
Health Care
NPR News: Merck Immunotherapy Drug Shines In Lung Cancer Study
Related Posts:
NPR News: FDA Approves Drug That Could Help Women With Postpartum Depression- NPR News: Health Plans For State Employees Use Medicare's Hammer On Hospital Bills
- NPR News: 'Mother Jones' Investigation Takes A Look At The World Of Drug Treatment Programs
- NPR News: Health Plans For State Employees Use Medicare's Hammer On Hospital Bills
- NPR News: FDA Approves Drug That Could Help Women With Postpartum Depression
0 nhận xét:
Đăng nhận xét